D. Robert Schemel's most recent trade in Panbela Therapeutics Inc. was a trade of 8,333 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2022 | 300,000 | 300,000 | - | - | Warrants (right to buy) | |
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2022 | 200,000 | 482,654 (7%) | 3% | - | Common Stock | |
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 12,368 | 12,368 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 4,316 | 96,619 (1%) | 0% | 0 | Common Stock | |
| Panbela Therapeutics Inc. | D. Robert Schemel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,875 | 92,303 (1%) | 0% | 0 | Common Stock |